Related Experiment Video

Updated: May 31, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical

Richard E Katholi1, Daniel M Couri

  • 1Prairie Cardiovascular Consultants, Ltd., 619 E. Mason Street, Ste. 4P57, Springfield, IL 62701, USA.

International Journal of Hypertension
|July 15, 2011
PubMed

Insights

Left ventricular hypertrophy (LVH) in hypertension is a risk factor for heart failure and sudden death. Regression of LVH through blood pressure control, lifestyle changes, and specific medications improves heart function and reduces cardiovascular risk.

Area of Science:

  • Cardiology
  • Hypertension Research

Background:

  • Left ventricular hypertrophy (LVH) is a detrimental adaptation to chronic pressure overload in hypertension.
  • LVH significantly increases the risk of atrial fibrillation, diastolic and systolic heart failure, and sudden cardiac death.
  • Identifying patients with hypertension who develop LVH is crucial for timely intervention.

Purpose of the Study:

  • To highlight clinical indicators for detecting LVH in hypertensive patients.
  • To discuss strategies for the regression of LVH.
  • To evaluate the impact of antihypertensive agents on LVH regression and cardiovascular outcomes.

Main Methods:

  • Review of clinical findings suggestive of LVH.
  • Assessment of lifestyle modifications (sodium restriction, weight loss) and their effect on LVH.
  • Evaluation of antihypertensive medication classes (ACE inhibitors, ARBs, CCBs) for LVH regression efficacy.

Main Results:

  • Specific clinical signs can prompt further evaluation of LVH via echocardiogram or cardiac MRI.
  • Independent regression of LVH is achieved through arterial pressure control, sodium restriction, and weight loss.
  • Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, followed by calcium channel antagonists, most effectively promote LVH regression.

Conclusions:

  • Regression of LVH improves diastolic function and coronary flow reserve.
  • Reducing LVH in hypertensive patients leads to a decreased overall cardiovascular risk.

More Related Videos

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice08:21

Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice

Published on: June 15, 2020

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...